Gastroparesis (GP) refers to when the stomach takes longer than usual to empty its contents into the small intestine.

Double-digit royalties on future net product sales3.5% equity stake in Intact Therapeutics HANOVER, Md., June 17, 2025 (GLOBE ...

Wolverhampton-born Talia Sinnott, 27, is currently receiving pioneering neurological treatment at the world-renowned Spero ...

A new study published in the journal of Cureus showed that while female patients with gastroparesis (GP) have longer hospital ...

Promising Glaucoma Pipeline Therapies such as EYEOP1, Latanoprost 0.005%, POLAT-001, Ranibizumab, Mitomycin (MMC), PRM-151, ...

Processa Pharmaceuticals' stock is surging after licensing a gastroparesis drug to Intact Therapeutics. The deal promises ...

Gastroparesis is a digestive disorder where ... Recognising gastroparesis symptoms early is key to timely gastroparesis treatment GASTROPARESIS CAUSES AND COMPLICATIONS: WHAT YOU NEED TO KNOW ...

There is no long-term treatment option currently available. CinDome’s deudomperidone is a new chemical entity being evaluated to address the unmet need in gastroparesis. Deudomperidone is a ...

Metoclopramide is used for the symptomatic treatment of post-operative or chemotherapy-induced nausea and vomiting, gastroesophageal reflux disease and gastroparesis. Metoclopramide is generally ...

Experts explain how Long Islanders can use medical cannabis to manage chronic pain safely, from product types to proper ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...